PharmAbcine, a clinical stage immune-oncology company, delivered a presentation at BIO DIGITAL 2021, June 10-11 & 14-18, 2021.

This presentation video features Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, who introduced the core technology and pipeline assets such as Olinvacimab, PMC-309, PMC-401s, and PMC-403.

Click the link for the video (Eng/Kor Sub available)

https://youtu.be/gcKBke_mpVw